Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)
Author(s) -
F. Perry Wilson,
Jeffrey S. Berns
Publication year - 2011
Publication title -
clinical nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.314
H-Index - 75
ISSN - 0301-0430
DOI - 10.5414/cn106993
Subject(s) - medicine , renal replacement therapy , dosing , dialysis , nephrology , vancomycin , intensive care medicine , acute kidney injury , hemodialysis , antibiotics , population , staphylococcus aureus , environmental health , biology , bacteria , microbiology and biotechnology , genetics
Continuous renal replacement therapy (CRRT) is frequently used in the intensive care setting for the treatment of acute kidney injury. Dosing guidelines for many commonly used antibiotics were established during intermittent dialysis or in studies examining CRRT at lower blood and dialysis flow rates than are used in common practice. Herein we present data demonstrating frequent subtherapeutic levels of vancomycin in a population of patients on CRRT. Nephrology trainees should be educated as to the risks of under-dosing antibiotics in this population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom